These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2068463)

  • 21. Clinical evaluation of aztreonam therapy for serious infections due to gram-negative bacteria.
    McKellar PP
    Rev Infect Dis; 1985; 7 Suppl 4():S803-9. PubMed ID: 3909340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of aztreonam in pediatric patients: a review.
    Bosso JA; Black PG
    Pharmacotherapy; 1991; 11(1):20-5. PubMed ID: 1902290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bacteriological, pharmacokinetic and clinical studies on aztreonam in the pediatric field. Pediatric Study Group of Aztreonam].
    Fuyii R; Meguro H; Arimasu O; Sunakawa K; Ishizuka Y; Nakazawa S; Sato H; Narita A; Matsumoto K; Suzuki H
    Jpn J Antibiot; 1985 Nov; 38(11):3195-216. PubMed ID: 3912524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical experience with aztreonam for treatment of infections in children.
    Stutman HR
    Rev Infect Dis; 1991; 13 Suppl 7():S582-5. PubMed ID: 2068462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of low-dose aztreonam in the treatment of moderate to severe infections due to gram-negative bacilli.
    Clergeot A; Steru D; Rosset MA; Carbon C
    Rev Infect Dis; 1991; 13 Suppl 7():S648-51. PubMed ID: 2068476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lumbar puncture in pediatric bacterial meningitis: defining the time interval for recovery of cerebrospinal fluid pathogens after parenteral antibiotic pretreatment.
    Kanegaye JT; Soliemanzadeh P; Bradley JS
    Pediatrics; 2001 Nov; 108(5):1169-74. PubMed ID: 11694698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aztreonam in the treatment of severe urinary tract infections in pediatric patients.
    Rusconi F; Assael BM; Boccazzi A; Colombo R; Crossignani RM; Garlaschi L; Rancilio L
    Antimicrob Agents Chemother; 1986 Aug; 30(2):310-4. PubMed ID: 3094442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of low dose aztreonam in the treatment of moderate to severe gram-negative bacterial infections.
    Clergeot A; Steru D; Rosset MA; Carbon C
    J Antimicrob Chemother; 1989 May; 23(5):753-8. PubMed ID: 2759924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of bacterial meningitis with once daily ceftriaxone therapy.
    Dankner WM; Connor JD; Sawyer M; Straube R; Spector SA
    J Antimicrob Chemother; 1988 May; 21(5):637-45. PubMed ID: 3391863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aztreonam in infections due to aerobic gram-negative bacteria.
    Allen KD; Green HT
    J Antimicrob Chemother; 1989 Feb; 23(2):290-2. PubMed ID: 2496072
    [No Abstract]   [Full Text] [Related]  

  • 31. Intravenous cefotaxime in children with bacterial meningitis.
    Belohradsky BH; Bruch K; Geiss D; Kafetzis D; Marget W; Peters G
    Lancet; 1980 Jan; 1(8159):61-3. PubMed ID: 6101414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Empiric antimicrobial therapy with aztreonam or ceftazidime in gram-negative septicemia.
    Lagast H; Klastersky J; Kains JP; van der Auwera P; Meunier F; Woussen F; Thijs JP
    Am J Med; 1986 May; 80(5C):79-84. PubMed ID: 3521272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aztreonam: review of the clinical experience and potential uses in pediatrics.
    Lebel MH; McCracken GH
    Pediatr Infect Dis J; 1988 May; 7(5):331-9. PubMed ID: 3288947
    [No Abstract]   [Full Text] [Related]  

  • 34. Cefuroxime versus ampicillin plus chloramphenicol in childhood bacterial meningitis: a multicenter randomized controlled trial.
    Marks WA; Stutman HR; Marks MI; Abramson JS; Ayoub EM; Chartrand SA; Cox FE; Geffen WA; Harrison CJ; Harrison D
    J Pediatr; 1986 Jul; 109(1):123-30. PubMed ID: 3522832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of gram-negative bacillary meningitis: role of the new cephalosporin antibiotics.
    Cherubin CE; Corrado ML; Nair SR; Gombert ME; Landesman S; Humbert G
    Rev Infect Dis; 1982; 4 Suppl():S453-64. PubMed ID: 6294799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In-vivo properties of SQ 26,776.
    Bonner DP; Whitney RR; Baughn CO; Miller BH; Olsen SJ; Sykes RB
    J Antimicrob Chemother; 1981 Dec; 8 Suppl E():123-30. PubMed ID: 6976961
    [No Abstract]   [Full Text] [Related]  

  • 37. Recent developments in the treatment of infectious diseases. 3. Bacterial meningitis.
    Marr JJ
    Mo Med; 1971 Aug; 68(8):612-8. PubMed ID: 4936084
    [No Abstract]   [Full Text] [Related]  

  • 38. Cefotaxime and aminoglycoside treatment of meningitis caused by gram-negative enteric organisms.
    Kaplan SL; Patrick CC
    Pediatr Infect Dis J; 1990 Nov; 9(11):810-4. PubMed ID: 2263430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Summary of worldwide clinical trials of aztreonam in patients with urinary tract infections.
    Swabb EA; Jenkins SA; Muir JG
    Rev Infect Dis; 1985; 7 Suppl 4():S772-7. PubMed ID: 3909336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of acute bacterial meningitis with special emphasis on beta-lactam antibiotics.
    Solberg CO; Haneberg B
    Scand J Infect Dis Suppl; 1984; 42():117-21. PubMed ID: 6597556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.